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Screening of six medicinal plant species 
for antileishmanial activity
This study is aimed to investigate the in vitro anti-
leishmanial activity of ethanolic, aqueous or dichlo-
romethane extracts of leaves, flowers, fruits or roots, 
of six medicinal plant species, namely, Nectandra 
megapotamica, Brunfelsia uniflora, Myrcianthes pungens, 
Anona muricata, Hymenaea stigonocarpa and Piper corco-
vandesis. After isolation and analysis of chemical com-
ponents by ultra-high performance liquid chromato-
graphy-high-resolution tandem mass spectrometry 
(UHPLC-HRMS/MS), the extracts were also tested for 
toxicity in J774.A1 macrophages and human erythro-
cytes. Phenolic acids, flavonoids, acetogenins, alka-
loids and lignans were identified in these extracts. 
Grow inhibition of promastigotes forms of Leishmania 
amazonensis and Leishmania braziliensis and the cyto-
toxicity in J774.A1 macrophages were estimated by 
the XTT method. The most promising results for L. 
amazonensis and L. braziliensis were shown by the etha-
nolic extract of the fruits of Hymenaea stigonocarpa and 
dichloromethane extract of the roots of Piper corco-
vadensis, with IC50 of 160 and 150 µg mL–1, resp. Etha-
nolic extracts of A. muricata (leaf), B. uniflora (flower 
and leaf), M. pungens (fruit and leaf), N. megapotamica 
(leaf), and aqueous extract of H. stigonocarpa (fruit) 
showed IC50 > 170 µg mL–1 for L. amazonensis and > 200 
µg mL–1 for L. braziliensis. The extracts exhibited low 
cytotoxicity towards J774.A1 macrophages with CC50 
> 1000 µg mL–1 and hemolytic activity from 0 to 
46.1 %.
Keywords: Piper corcovadensis, Hymenaea stigonocarpa, 
antileishmanial, Leishmania amazonensis, Leishmania 
braziliensis, cytotoxicity, hemolysis
Leishmaniasis is an infectious disease caused by protozoa of the genus Leishmania. 
The clinical manifestations depend on the species of Leishmania and the host immune re-
sponse. Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis and 
FABIANA BORGES PADILHA FERREIRA1 
MÁRCIA REGINA PEREIRA CABRAL2 
MARIA HELENA SARRAGIOTTO3 
CARLA MARIA MARIANO FERNANDEZ4 
ZILDA CRISTIANI GAZIM4 
RANULFO PIAU JUNIOR5 
IZABEL GALHARDO DEMARCHI6 
THAÍS GOMES VERZIGNASSI SILVEIRA1,7 
MARIA VALDRINEZ CAMPANA LONARDONI1,7
1 Posgraduate Program in Health Sciences 
Maringá State University, Maringá – Paraná 
State, Brazil
2 Posgraduate Program in Pharmaceutical 
Sciences, Maringá State University, Maringá – 
Paraná State, Brazil
3 Postgraduate Program in Chemistry, Maringá 
State University, Maringá – Paraná, Brazil
4 Posgraduate Program in Biotechnology Applied 
to Agriculture, Universidade Paranaense 
UNIPAR, Umuarama – Paraná State, Brazil
5 Posgraduate Program in Animal Science of the 
University of Paranaense, Universidade 
Paranaense UNIPAR, Umuarama – Paraná 
State, Brazil
6 Federal University of Santa Catarina, 
Florianópolis – Santa Catarina State, Brazil
7 Department of Clinical Analysis and 
Biomedicine, Maringá State University 
Maringá – Paraná State, Brazil
Accepted July 23, 2020 
Published September 3, 2020
* Correspondence; e-mail: fabianabpferreira@gmail.com; fbpferreira@hotmail.com
400
F. B. Padilha Ferreira et al.: Screening of six medicinal plant species for antileishmanial activity, Acta Pharm. 71 (2021) 399–414.
 
causes skin lesions, mainly ulcers on exposed body parts, leaving life-long scars and seri-
ous disability or stigma. Leishmania braziliensis is associated with the cutaneous and muco-
cutaneous form (MCL), whereas Leishmania amazonensis is related to the diffuse cutaneous 
forms (DCL) (1). MCL and DCL are the most severe forms due to the destructive disfigur-
ing lesions, which can result in increased individual and social stigma as well as suicidal 
ideas (2). Approximately 95 % of cutaneous leishmaniasis occur in the American continent, 
Mediterranean bay, Middle-East and Central Asia. The World Health Organization has 
estimated that about 600 thousand to 1 million new cases occur worldwide a year, and 
more than 90 % of the cases of MCL occur in Bolivia, Brazil, Peru and Ethiopia (3).
For decades, the first choice to treat this disease has been the utilization of pentavalent 
antimony, and the second choice has utilized treatment drugs such as amphotericin B and 
pentamidine. However, these drugs present high toxicity, resistance and parenteral admi-
ni stration, high cost and relatively long treatment regimen (4). Other drugs have also been 
used as an alternative tool in cases of therapeutic failure, abandon and parasitic resistance, 
such as imidazole, miltefosine, paromomycin and liposomal amphotericin B. Nevertheless, 
not all the drugs are available or accessible to the most affected populations, making neces-
sary to search for new sources of bioactive molecules essential to discover new medicines 
and alternative therapies (5).
Over the years, humans have been using nature to treat a broad spectrum of diseases, 
mainly infectious and parasitic ones (6). The need for new, safer and more effective treat-
ments of leishmaniasis stimulated research with natural products obtained from plants 
with antileishmanial activity. A lot of studies have shown the potential of medicinal plants 
to treat several diseases, working as a base for the formulation of phytotherapeutic drugs 
or as a source to obtain active principles (7).
In this context, this study is aimed to chemically characterize nine extracts belonging 
to six different medicinal plants belonging to different families, to investigate their effects 
on the promastigote forms of L. amazonensis and L. braziliensis, and also, evaluate their 
cytotoxicity to J774.A1 macrophages and erythrocytes.
EXPERIMENTAL
Plant material
The exsiccata data and the location of the collection are presented in Table I for five 
native species of Brazil: Brunfelsia uniflora (Pohl.) David Don, Hymenaea stigonocarpa Mar-
tius ex. Hayne, Myrcianthes pungens (Otto Berg) Diego Legrand, Nectandra megapotamica 
(Spreng) Mez and Piper corcovadensis (Miq.) C. DC, and one introduced and well-acclimated 
species in Brazil, Annona muricata Linnaeus.
Crude extracts. – The crude extracts of N. megapotamica leaves, B. uniflora leaves and 
flowers, M. pungens fruits and leaves and H. stigonocarpa fruits were obtained by dynamic 
maceration utilizing 96 % (V/V) ethanol as solvent. For the fruits of H. stigonocarpa, an aque-
ous extract was prepared. The crude extract of A. muricata leaves was obtained in 95 % 
(V/V) ethanol. For the P. corcovandesis, roots were extracted in dichloromethane using a 
Soxhlet apparatus. All extracts were concentrated in a rotary evaporator (Tecnal®, TE-211, 
Brazil) at 40 °C to obtain the crude extracts. 
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Ultra-high performance liquid chromatography – high-resolution tandem mass spectro-
metry (UHPLC-HRMS/MS)
The extracts were analyzed by UHPLC (Nexera X2, Shimadzu, Japan) coupled with 
HRMS (QTOF Impact II, Bruker Daltonics Corporation, USA) equipped with an electro 
-spray ionization source. The capillary voltage was operated in negative and positive ioni-
zation mode, set at 4500 V, and with an endplate offset potential of –500 V. The dry gas 
parameters were set at 8 L min–1 at 200 °C with a nebulization gas pressure of 4 × 105 Pa. 
Data were collected from m/z 50 to 1300 with an acquisition rate of 5 spectra per second, 
and the ions of interest were selected by auto MS/MS scan fragmentation. Chromatographic 
separation was performed using a C18 column (75 × 2.0 mm i.d., 1.6 µm, Shim-Pack  XR-ODS 
III, Shimadzu). The gradient mixture of solvents A (H2O) and B (acetonitrile) was as 
 follows: 5 % B 0–1 min, 30 % B 1–2 min, 95 % B 2–8 min, maintained at 95 % B 8–12 min, at 
40 °C. The identification of the compounds was proposed from a review of secondary 
metabolites found in species belonging of the genus Brunfelsia, Hymenaea, Myrcianthes, 
Nectandra, Piper and Annona. In addition, the mass error value was considered (the differ-
ence between the calculated exact mass and the experimental exact mass) (8). The mass 





× 10 in ppm (parts p6
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Cultivation and maintenance of promastigote forms
Promastigote forms of L. amazonensis (MHOM/BR/1977/LTB0016) were provided by 
the Leishmania Collection from Oswaldo Cruz Institute (CLIOC, Rio de Janeiro, Brazil) and 
L. braziliensis (MHOM/BR/1987/M11272) were isolated from the patient carriers of Ameri-
can cutaneous leishmaniasis, attending the Laboratório de Ensino e Pesquisa em Análises 
Clínicas of the Maringá State University, Brazil, identified in the Instituto Evandro Chagas, 
Brazil (9). Promastigote forms were cultivated and kept at 25 °C through weekly trans-
plants in cultivation medium 199 (Sigma-Aldrich, USA) supplemented with 10 % (V/V) 
fetal bovine serum (FBS, Cultilab, Brazil), 2 mmol L–1 l-glutamine and antibiotics (100 IU 
mL–1 penicillin and 0.1 µg mL–1 streptomycin (Sigma-Aldrich).
Antileishmanial activity
To evaluate the growth inhibition of promastigote forms of Leishmania, the parasites 
were cultivated until they reached the stationary phase. A suspension was prepared in 
RPMI 1640 medium to contain 4 × 107 mL–1 of parasites.
The parasite’s viability was determined using the colorimetric method based on the 
reduction of the tetrazolium salt (XTT, 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide) (Sigma-Aldrich) to formazan, a colored, water-soluble compound 
(10). Briefly, the extracts were dissolved in Tween 80 and serially diluted with RPMI 1640 
(Sigma-Aldrich, USA) from 1000 to 1.5 µg mL–1 in 96-well culture plates (TPP, Switzerland). 
Amphotericin B (AmB, Laboratório Cristalia, Brazil) was diluted in RPMI 1640 from 125 to 
0.24 µg mL–1. A suspension in RPMI medium of L. amazonensis promastigote forms (100 µL) 
from a logarithmic growth phase (4 x 106 parasites per 100 µL) was added to each well. 
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After 24-h incubation at 25 °C, 100 µL of a solution containing XTT (0.2 mg mL–1) and 
 phenazine methosulfate (PMS, Sigma, USA) (0.2 mmol L–1) were added to each well.
The plates were incubated for 3 h at 37 °C. The results were measured in a microplate 
reader (ASYS Expert Plus, ASYS Hitech GmbH, Austria) at 450/620 nm. Amphotericin B 
was utilized as a reference drug and positive control of the treatment (parasite death). The 
IC50 (minimum concentration for 50 % inhibition) was calculated from a polynomial 
 regression of the data comparing it to the negative control (non-treated parasites). The tests 
were performed in duplicate and replicated at least three times.
Cytotoxicity against J774.A1 macrophages
J774.A1 macrophages were cultivated in RPMI 1640 medium and distributed in 96-
well plates at the concentration of 1 × 106 cells mL–1 at 37 °C in an atmosphere containing 5 
% of CO2. Then, the cultivation medium was removed and the cells were washed several 
times with RPMI 1640 to remove non-adherent cells. The extract (1000 to 1.5 µg mL–1) was 
added to each well. After 24 h of cultivation, 100 µL of XTT was added to each well. The 
plates were incubated for 3 h, and the absorbance was measured by a microplate reader at 
450/620 nm. The cytotoxic concentration sufficient to inhibit macrophages by 50 % (CC50) 
was calculated by the polynomial regression of data compared to the control of non-treat-
ed cells. The selectivity index (SI) was determined using the following equation:
SI = CC50 in cells/IC50 in Leishmania
The tests were performed in duplicate and replicated at least three times.
Hemolytic activity
The toxicity to red blood cells was determined according to the method described by 
Valdez et al. (11) with modifications. Human blood samples were obtained by venipuncture 
from six healthy women donors, aged 21–60 years old, non-smokers, who were not on any 
medication, and suffered from no chronic diseases. The donors completed “Consent form” 
agreeing to participate in the research. Approval of the Ethics Committee has been obtained.
Briefly, a 6 % suspension of fresh defibrinated human blood was prepared in sterile 1 % 
glucose saline solution. The extracts were serially distributed into culture plates (96 wells) 
at concentrations ranging from 1000 to 1.5 µg mL–1. In sequence, 100 µL of suspension of red 
blood cells was added. After 2 h of incubation at 37 °C, the culture plates were centrifuged 
at 3000 g for 5 min (Rotina 420, Hettich, Germany), and the hemolysis was measured in the 
supernatant using a microplate reader (Asys Hitech, Austria) at 550 nm. A 4 % solution of 
Triton X-100 (Sigma-Aldrich) was utilized as a positive control, whereas the suspension of 
non-treated cells was used as a negative control. The solvent used in the negative control 
was sterile 1 % glucose saline solution. The results were expressed in the hemolysis percent-
age. The tests were performed in duplicate and replicated at least three times.
Statistical analysis
The results were first analyzed by the Shapiro-Wilk test to verify the normality distri-
bution of the data. Given the assumption of normality, the data were subjected to analysis 
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of variance by the F-test and the means were analyzed by the Scott-Knott test. Statistical 
differences were considered significant with p-value of less than 0.05.
RESULTS AND DISCUSSION
Chemical characterization
In this study, nine extracts obtained from plants belonging to six different botanical 
families were selected, and their botanical name, traditional use and biological activity 
described in the literature are presented in Table I. We have performed a qualitative analy-
sis of these plants parts by UHPLC-HRMS/MS, in positive and negative mode (Table II), as 
well as the antileishmanial activity against promastigote forms of L. amazonensis and L. 
braziliensis (Table III).
The chemical analysis of the aqueous extract of H. stigonocarpa fruits identified epicate-
chin and flavonoid glycoside, nicotiflorin, and epicatechin in the ethanolic extract. Fig. 1 
shows a representative chromatogram (negative mode) of the ethanolic extract (Fig. 1a) and 
aqueous extract (Fig. 1b) of H. stigonocarpa fruits. Epicatechin was one of the main com-
pounds present in the sap extracted by the perforation of the trunk and stem bark of H. 
stigonocarpa in a study by Farias et al. (18). Veggi et al. (19) and Sasaki et al. (20) found epi-
catechin in H. courbaril bark extract. A study of the phytochemical profile of methanolic 
extract of stem barks and fruit pulp of H. stigonocarpa indicated the presence of phenolic 
compounds, mainly flavonoids and condensed tannins (21).
The compounds piperlonguminine, chingchengenamide, piperine and piperolide 
were identified in the dichloromethane extract from the roots of P. corcovadensis (Figs. 2 
a,b). The piperlonguminine was also recognized by Costa and Mors (22) as a constituent 
of P. corcovadensis roots extract. Facundo et al. (23) isolated chingchengenamide. Piperine 
was isolated by Bezerra et al. (24) in P. tuberculatum root extract, whereas Mata et al. (25) 
identified piperolide in the extract of P. sanctum. Thus, the results found in the present 
work are in agreement with the ones previously reported in the literature regarding the 
composition of the dichloromethane extract from the roots of P. corcovadensis.
From the ethanolic extract of A. muricata leaves the chromatogram was obtained in the 
negative (Fig. 3a) and positive (Fig. 3b) ionization mode; it was possible to identify the pres-
ence of flavonoids (rutin, nicotiflorin and quercitrin), acetogenins (annomuricin A, anno-
reticuin-9-one and annonacin) and alkaloids (isoboldine and liriodenine). Rutin (26), nico-
tiflorin (27), quercitrin (28), annonacin and annomuricin (29), annoreticuin-9-one (30), 
liriodenine (31) and isoboldine (32) have already been isolated from A. muricata extract in 
the previous studies. Acetogenins were mainly obtained from leaves, roots and seeds and 
to a lower portion from the stem of A. muricata (33).
Phenolic compounds derived from cinnamic acid (caffeic acid, chlorogenic acid and 
ferulic acid), coumarin (scopoletin), an alkaloid (brunfelsamidine) and flavonoid (rutin) 
were identified in ethanolic extract of B. uniflora flowers (Fig. 4a,b), whereas scopoletin and 
brunfelsamidine were found in ethanolic extract of B. uniflora leaves (Fig. 5a,b). The pres-
ence of scopoletin isolated from the roots of B. uniflora ethanolic extract has been already 
reported (34), as well as caffeic and chlorogenic acid of the leaves (35). The alkaloid brun-
felsamidine is present in the leaves, stems and roots of this same species (36).
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The results obtained by 
phytochemical analysis of M. 
pungens indicated the presence 
of gallic acid and isoquercitrin 
in the ethanolic extract of the 
fruits (Fig. 6a) and gallic acid, 
isoquercitrin, quercetin and 
quercitrin in the ethanolic ex-
tract of the leaves of M. pungens 
(Fig. 6b). De Almeida et al. (37) 
identified the flavonoids quer-
cetin and quercitrin in the 
leaves extract of M. pungens. In 
the extract of the fruit, Andrade 
et al. (15) found quercitrin and 
isoquercitrin, whereas Seraglio 
et al. (38) detected gallic acid 
and isoquercetrin, corroborat-
ing well to our results. Querce-
tin and quercitrin have also 
been previously reported to 
have in vitro antileishmanial ac-
tivity against L. amazonensis (39, 
40).
Epicatechin, rutin, nectan-
drin B and galgravin were 
identified in the ethanolic ex-
tract of N. megapotamica leaves 
(Fig. 7a,b). The tetrahydrofuran 
lignan known as nectandrin B 
and galgravin were isolated 
from crude ethanolic extract of 
the leaves of N. megapotamica in 
a study by Silva-Filho et al. (41), 
corroborating with our results. 
Garcez et al. (16) identified epi-
catechin in the extract of N. 
megapotamica stem bark.
Antileishmanial activity
This study demonstrated 
that extracts from several plant 
species inhibited the growth of 
both L. amazonensis and L. bra-
ziliensis. The ethanolic extract 
of H. stigonocarpa fruits and di-
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Fig. 2. Chromatographic profile of dichloromethane extract from the roots of Piper corcovadensis obta-
ined by UHPLC-HRMS/MS: a) negative mode, b) positive mode.
Fig. 1. Chromatographic profile of Hymenaea stigonocarpa fruit extracts obtained by UHPLC-HRMS/
MS in negative mode: a) ethanolic extract, b) aqueous extract.
Fig. 3. Chromatographic profile of the ethanolic extract of the leaves of Annona muricata obtained by 
UHPLC-HRMS/MS: a) negative mode, b) positive mode. 
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Fig. 5. Chromatographic profile of ethanolic extract of the leaves of Brunfelsia uniflora obtained by 
UHPLC-HRMS/MS: a) negative mode, b) positive mode.
Fig. 4. Chromatographic profile of the ethanolic extract of the flower of Brunfelsia uniflora obtained by 
UHPLC-HRMS/MS: a) negative mode, b) positive mode.
Fig. 6. Chromatographic profile of Myrcianthes pungens ethanolic extracts obtained by UHPLC-HRMS/
MS in negative mode: a) fruits, b) leaves.
409
F. B. Padilha Ferreira et al.: Screening of six medicinal plant species for antileishmanial activity, Acta Pharm. 71 (2021) 399–414.
 
chloromethane extract from the roots of P. corcovadensis were the most active against both 
protozoans, not differing statistically from each other (Table III).
The IC50 values for H. stigonocarpa ethanolic extract were 170 µg mL–1 for L. amazonensis 
and 160 µg mL–1 for L. braziliensis, whereas for the aqueous extract it was 190 and 200 µg mL–1, 
resp. Ribeiro et al. (42) found IC50 of 199 µg mL–1 for hexane extract of H. stigonocarpa leaves 
against L. amazonensis, results similar to those found for H. stigonocarpa fruit extracts in our 
study.
Dichloromethane extract from the roots of P. corcovadensis presented IC50 of 150 
µg mL–1 for both L. amazonensis and L. braziliensis. In studies with other Piper species, IC50 
results were similar to those found in this paper. Nakamura et al. (43), in a survey with 
extract of Piper regnellii leaves, found IC50 of 167 µg mL–1 for hydroalcoholic extract, Sales et 
al. (44) found IC50 of 143 µg mL–1 for the essential oil of Piper tuberculatum Jacq. fruit against 
L. braziliensis. Piperlongumine, an alkaloid amide isolated from P. tuberculatum, showed 
antileishmanial activity against L. infantum and L. amazonensis (45).
The ethanolic extract of A. muricata leaves, ethanolic extract of B. uniflora leaves and 
flowers, the aqueous extract of H. stigonocarpa fruits, ethanolic extract of M. pungens leaves 
and fruits, and ethanolic extract of N. megapotamica leaves showed IC50 from 180 to 540 µg 
mL–1 against L. amazonensis, whereas against L. braziliensis it varied from 200 to 760 µg mL–1 
(Table III). The IC50 shown by amphotericin B was 0.00053 µg mL–1 for L. amazonensis and 
0.0015 µg mL–1 for L. braziliensis.
Acetogenins in the ethanolic extract of A. muricata leaves were probably responsible 
for the observed antileishmanial activity (46). Although a clear structure-activity relation-
ship has not yet been established for acetogenins, their leishmanicidal activity can be at-
tributed to the number of hydroxy groups or the presence of a single tetrahydrofuran ring 
in their structure (47).
Cytotoxicity in macrophages J774.A1
To assess the potential application of the tested extracts in the treatment of leish-
maniasis, the absence of toxicological effects against the host is required (48). Therefore, 
Fig. 7. Chromatographic profile of the ethanolic extract of Nectandra megapotamica leaves obtained by 
UHPLC-HRMS/MS: a) negative mode, b) positive mode.
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the possible cytotoxic effects of the extracts on J774.A1 macrophages and human red blood 
cells were evaluated. Our results indicated that the ethanolic and aqueous extracts of H. 
stigonocarpa fruits, dichloromethane extract from the roots of P. corcovadensis, ethanolic 
extract of N. megapotamica leaves and ethanolic extract of B. uniflora leaves showed low 
cytotoxicity for J774.A1 macrophages with CC50 > 1000 µg mL–1 (Table III). The selectivity 
index (SI) was higher than 1 for all extracts evaluated, indicating a greater selectivity 
against the parasite in relation to mammal cells. These results are supported by Almeida 
et al. (49) and Tiuman et al. (50), who standardized the selectivity index over 1, suggesting 
that it indicates higher activity against protozoa and smaller activity against mammal 
cells.
Hemolytic activity
The extracts exerted low cytotoxicity in human red blood cells. The percentage of 
hemolysis ranged from 0 to 1.3 % at the highest concentration tested (1000 µg mL–1), except 
for dichloromethane extract from the roots of P. corcovadensis which caused 46.1 % hemo-
lysis (Table III). In a study by Mello et al. (51) amphotericin B showed a strong hemolytic 
effect, causing 100 and 84.07 % hemolysis at 0.13 and 0.01 mmol L–1, resp. Valdez et al. (11) 
also demonstrated a high percentage of hemolysis of amphotericin, 70 % at 0.01 mmol L–1, 
concentration much lower than that used in our work.
CONCLUSIONS
In search of new substances with potential antileishmanial action, the extracts of H. 
stigonocarpa fruits and P. corcovadensis roots showed promising activity against L. amazo-
nensis and L. braziliensis, and might be a potential source of active and less toxic com-
pounds for the development of novel therapeutic agents to treat leishmaniasis. To the best 
of our knowledge, this is the first report on these species against two species of Leishmania. 
Additional experiments should be performed to isolate the active constituents of the most 
active plants, as well as to evaluate in vivo models for the treatment of these diseases.
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